no way they even break even for 2012. why did I buy so much of this TP? pretty sad earnings and projections. Maybe they need to go after Hep D, E and F soon to get more revenue. bring boogger back now and fire the CEO
pretty sad. forget mid 50s' for a few quarters. how the heck did they lose 61MM bucks on 337MM revenue??? no wonder they did partnerships. they better get a new drug in clinical trial to hit soon or this is going to the 30's. someone buy them out at $55 please. mgt would take that offer as that's better than $35 and they will let someone run the company that knows how to. Bring boogger back fast.